Identical TP53 mutations provide evidence that late‐recurring tubo‐ovarian high‐grade serous carcinomas do not represent new peritoneal primaries

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles